Clinical Trials
51 trialsMagMen-II
Vastra Gotaland Region
Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica.
Caja Costarricense de Seguro Social
MEL
Institute of Health Information and Statistics of the Czech Republic
CNN-Based AI Versus Physicians for Solitary Skin Lesion Diagnosis
Istanbul Training and Research Hospital
HFUS-CLEAR
Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
NEOPRIME
Vastra Gotaland Region
Vellus Hair Loss as a Marker for Peri-ocular Malignancy
NHS Lothian
AI-DSSC
Linkoeping University
MEL-CARE
Ankara Etlik City Hospital
HAITILS
Vastra Gotaland Region
GoTIL-01
Vastra Gotaland Region
MK3475-C01
Sheba Medical Center
Head and Neck Melanoma; Access to Staging and Surgical Treatment
Hull University Teaching Hospitals NHS Trust
SCANDIUM II
Vastra Gotaland Region
WoW
Vastra Gotaland Region
AI-DSMM
Linkoeping University
ClearMark
Hull University Teaching Hospitals NHS Trust
AI-DSII
Vastra Gotaland Region
CANSI
Turku University Hospital
SCANDIUM-III
Vastra Gotaland Region
Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer
Henan Cancer Hospital
L-TIL Plus Tislelizumab as First-line Treatment in Advanced Malignant Melanoma
Henan Cancer Hospital
NivoILP
Vastra Gotaland Region
ILP-NfL
Vastra Gotaland Region
SCANDIUM
Vastra Gotaland Region
ILP-Prime
Vastra Gotaland Region
SurgMelMet
Vastra Gotaland Region
SUMMIST
Vastra Gotaland Region
OASIS
Cardiff and Vale University Health Board
PEMDAC
Vastra Gotaland Region
LifeChamps Feasibility Study
Region Stockholm
An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas
Fujian Cancer Hospital
HAITILS-PHP
Vastra Gotaland Region
Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma
Fujian Cancer Hospital
Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients
Sheba Medical Center
Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection
Instituto Nacional de Cancer, Brazil
Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin Cancers
Zagazig University
Photographic Rhinometry Following Derm/Mohs Surgery for Skin Cancers
NHS Grampian
Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors
Sheba Medical Center
PAMela
Azienda USL Reggio Emilia - IRCCS
CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL
Shandong Provincial Hospital
PRIMM
East and North Hertfordshire NHS Trust
Apatinib Plus SHR1210 in Advanced Mucosal Melanoma
Henan Cancer Hospital
Fecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed Immunotherapy
Sheba Medical Center
Clinical Study of Apatinib as the Second-line Therapy in Malignant Melanoma
Henan Cancer Hospital
E3N
Institut National de la Santé Et de la Recherche Médicale, France
Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol
Vastra Gotaland Region
Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients
Sheba Medical Center
Confocal Microscopy of Benign and Malignant Skin Tumors
Sheba Medical Center
A Randomised Study Comparing Tissue Conservation in Conventional Versus Mohs' Surgery of Basal Cell Carcinoma
NHS Tayside